Chief Financial Officer · Perspective Therapeutics, Inc. (CATX)

Jonathan Hunt

A named executive officer of Perspective Therapeutics in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,495,898

Salary $447,365

FY2023: $1,169,963

3rd of 3 named executive officers at Perspective Therapeutics by FY2024 total.

3 named officers on file for Perspective Therapeutics, FY2024

Jonathan Hunt’s pay file — $29

  • 2 fiscal years of pay, line by line
  • CATX’s disclosed peer group of 25 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Perspective Therapeutics’s whole pay program stands against its peers

  • Perspective Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CATX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 16, 2025 (DEF 14A).

Free

Get Jonathan Hunt’s full pay file as a PDF — free

More than this page: up to 10 years of Jonathan’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jonathan Hunt compensation by year

Perspective Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Perspective Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$389,154$447,365
Bonus$30,000$0
Stock awards$0—
Option awards$225,609$884,733
Non-equity incentive$172,000$150,000
Pension and deferred compensation$0—
All other$353,200$13,800
Total$1,169,963$1,495,898

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Perspective Therapeutics, Inc. DEF 14A filed April 16, 2025, accession 0000950170-25-054776, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Perspective Therapeutics, Inc. filed document, accession 0000950170-25-054776. Every figure is read from that document and cited to the page and table it appears in. Filed April 16, 2025.

$1.2M
$1.5M
FY23
FY24
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
Option62,438—$2.40
Option87,500—$10.65

Per the Outstanding Equity Awards at Fiscal Year-End table in Perspective Therapeutics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Perspective Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Johan SpoorChief Executive Officer, Director$5,371,889
Markus PuhlmannChief Medical Officer$2,029,343
Jonathan Hunt · this pageChief Financial Officer$1,495,898

The full Perspective Therapeutics compensation record

free company brief

This page is one person within Perspective Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Perspective Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Perspective Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jonathan Hunt's compensation dossier · One-time report. No refunds.